Evidence map›Paper›PMID 35327622›Full record

ReviewBiomolecules2022

The Mechanisms of Restenosis and Relevance to Next Generation Stent Design.

Jessie Clare, Justin Ganly, Christina A Bursill, Huseyin Sumer, Peter Kingshott, Judy B de Haan

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Liraglutide Ameliorates Injury-Related Vascular Repair by Activating Autophagy Through Modulation of the PI3K-mTOR Signaling Pathway.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  10. Single centre experience of rotablation-assisted left main percutaneous coronary intervention.American heart journal plus : cardiology research and practice · 2026
    Article
  11. Review
  12. Article
  13. Drug-Eluting Balloons Versus Conventional Balloons in Treatment of Coronary Bifurcation Lesions in Small Vessels.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Article
  14. Review
  15. Article
  16. Comparison of Different PCI Strategies for Coronary DES In-stent Restenosis: A Bayesian Network Meta-analysis.Journal of the Society for Cardiovascular Angiography & Interventions · 2025
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jessie ClareDepartment of Chemistry and Biotechnology, Swinburne University of Technology, Melbourne, VIC 3122, Australia.ORCID 0000-0002-4348-7352
Justin GanlyDepartment of Chemistry and Biotechnology, Swinburne University of Technology, Melbourne, VIC 3122, Australia.ORCID 0000-0002-2188-3813
Christina A BursillAdelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5000, Australia.ORCID 0000-0002-0682-8760
Huseyin SumerDepartment of Chemistry and Biotechnology, Swinburne University of Technology, Melbourne, VIC 3122, Australia.ORCID 0000-0001-9413-5579
Peter KingshottDepartment of Chemistry and Biotechnology, Swinburne University of Technology, Melbourne, VIC 3122, Australia.
Judy B de HaanDepartment of Chemistry and Biotechnology, Swinburne University of Technology, Melbourne, VIC 3122, Australia.
Baker Heart and Diabetes Institute · AUSwinburne University of Technology · AUSouth Australian Health and Medical Research Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stents are lifesaving mechanical devices that re-establish essential blood flow to the coronary circulation after significant vessel occlusion due to coronary vessel disease or thrombolytic blockade. Improvements in stent surface engineering over the last 20 years have seen significant reductions in complications arising due to restenosis and thrombosis. However, under certain conditions such as diabetes mellitus (DM), the incidence of stent-mediated complications remains 2-4-fold higher than seen in non-diabetic patients. The stents with the largest market share are designed to target the mechanisms behind neointimal hyperplasia (NIH) through anti-proliferative drugs that prevent the formation of a neointima by halting the cell cycle of vascular smooth muscle cells (VSMCs). Thrombosis is treated through dual anti-platelet therapy (DAPT), which is the continual use of aspirin and a P2Y

Indexed as

Coronary RestenosisDrug-Eluting StentsPercutaneous Coronary InterventionThrombosisHumansInflammationNeointimaStentsdrug-eluting stentsinflammationneointimal hyperplasiaredoxrestenosis

Identifiers

PMID35327622
PMCPMC8945897
OpenAlexW4220992149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.